Venture Capital

Saluda Medical: $100 Million Of Financing Closed

By Amit Chowdhry ● Jan 13, 2025

Saluda Medical - a commercial-stage medical device company focused on developing treatments for chronic neurological conditions utilizing a novel closed-loop and dose-control neuromodulation platform - announced the closing of a $100 million financing.

Normunity: $75 Million (Series B) Raised For Broadening Pipeline Of Novel Anti-Cancer Therapies

By Amit Chowdhry ● Jan 13, 2025

Normunity, a biotechnology company creating novel anti-cancer therapies, announced today that it closed a Series B funding round of $75 million. The funding was co-led by Samsara BioCapital and Enavate Sciences, alongside other new investors Regeneron Ventures, Pfizer Ventures and YK Bioventures, as well as existing investors Canaan Partners, Sanofi Ventures, Taiho Ventures, Osage Venture Partners, HongShan Capital Group, and Connecticut Innovations. And the Board of Directors will be expanded to include David Parry, PhD (Samsara), Sara Nayeem, MD (Enavate), and Marie-Clare Peakman, MD (Pfizer Ventures).

Tidal Cyber Buying Zero-Shot Security

By Amit Chowdhry ● Jan 13, 2025

Tidal Cyber, the Threat-Informed Defense company, announced the acquisition of Zero-Shot Security, the creator of an innovative artificial intelligence (AI) solution that simplifies and speeds the processing and analysis of threat intelligence.

R4 Capital: $10.6 Billion Surpassed In 2024

By Amit Chowdhry ● Jan 13, 2025

R4 Capital, a national affordable housing tax-credit syndicator, lender, and asset manager, and R4 Capital Funding (R4CF), R4's tax-exempt lending platform, announced in 2024 that it surpassed $10.6 billion in equity and mortgage financing since being founded. This was a significant year, marking the most equity closed in a single year, the largest mortgage loan volume closed in a single quarter, and the most important single asset equity investment in the company's history.

IQHQ: $900 Million Raised In 2024

By Amit Chowdhry ● Jan 13, 2025

IQHQ - a premier owner and developer of life science districts - announced that $900 million of new capital was raised in 2024, with the most recent closing occurring in December 2024.

Holly: AI-Based Government Hiring Platform Raises $2.2 Million

By Amit Chowdhry ● Jan 13, 2025

Holly, an AI-based platform modernizing government hiring, announced the closing of its $2.2 million oversubscribed pre-seed round, led by J2 Ventures with participation from Roble Ventures, Gaingels, and notable angel investors. And the funding will support Holly's platform as it works to solve the million-job government workforce vacancy crisis.

Ascend Capital Partners Acquires Majority Stake in Unison Therapy Services

By Amit Chowdhry ● Jan 13, 2025

Ascend Capital Partners - a healthcare-focused private equity firm dedicated to improving the access, affordability, and quality of healthcare for vulnerable and underserved populations - announced that it has acquired a majority stake in Unison Therapy Services, one of the largest outsourced therapy providers for Pre-K – 12 students in school- and community-based settings.

Tune Therapeutics: Over $175 Million (Series B) Raised For Advancing Field-Leading Epigenome Editing Programs

By Amit Chowdhry ● Jan 13, 2025

Leading epigenome editing company Tune Therapeutics announced the completion of over $175 million in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures, and Hevolution Foundation.